Gutmann DH - Search Results

1

Next Directions in the Neuroscience of Cancers Arising outside the CNS.

Amit M, Anastasaki C, Dantzer R, Demir IE, Deneen B, Dixon KO, Egeblad M, Gibson EM, Hervey-Jumper SL, Hondermarck H, Magnon C, Monje M, Na'ara S, Pan Y, Repasky EA, Scheff NN, Sloan EK, Talbot S, Tracey KJ, Trotman LC, Valiente M, Van Aelst L, Venkataramani V, Venkatesh HS, Vermeer PD, Winkler F, Wong RJ, Gutmann DH, Borniger JC. Amit M, et al. Among authors: gutmann dh. Cancer Discov. 2024 Apr 4;14(4):669-673. doi: 10.1158/2159-8290.CD-23-1495. Cancer Discov. 2024. PMID: 38571430

2

Mouse models of human cancer consortium symposium on nervous system tumors.

Gutmann DH, Baker SJ, Giovannini M, Garbow J, Weiss W. Gutmann DH, et al. Cancer Res. 2003 Jun 1;63(11):3001-4. Cancer Res. 2003. PMID: 12782610

3

Neurofibromatosis type 1 - a model for nervous system tumour formation?

Rubin JB, Gutmann DH. Rubin JB, et al. Among authors: gutmann dh. Nat Rev Cancer. 2005 Jul;5(7):557-64. doi: 10.1038/nrc1653. Nat Rev Cancer. 2005. PMID: 16069817 Review.

4

Neurofibromatosis type 1: modeling CNS dysfunction.

Gutmann DH, Parada LF, Silva AJ, Ratner N. Gutmann DH, et al. J Neurosci. 2012 Oct 10;32(41):14087-93. doi: 10.1523/JNEUROSCI.3242-12.2012. J Neurosci. 2012. PMID: 23055477 Free PMC article. Review.

5

Neuronal NF1/RAS regulation of cyclic AMP requires atypical PKC activation.

Anastasaki C, Gutmann DH. Anastasaki C, et al. Among authors: gutmann dh. Hum Mol Genet. 2014 Dec 20;23(25):6712-21. doi: 10.1093/hmg/ddu389. Epub 2014 Jul 28. Hum Mol Genet. 2014. PMID: 25070947 Free PMC article.

6

Elucidating the impact of neurofibromatosis-1 germline mutations on neurofibromin function and dopamine-based learning.

Anastasaki C, Woo AS, Messiaen LM, Gutmann DH. Anastasaki C, et al. Among authors: gutmann dh. Hum Mol Genet. 2015 Jun 15;24(12):3518-28. doi: 10.1093/hmg/ddv103. Epub 2015 Mar 18. Hum Mol Genet. 2015. PMID: 25788518 Free PMC article.

7

NF1 germline mutation differentially dictates optic glioma formation and growth in neurofibromatosis-1.

Toonen JA, Anastasaki C, Smithson LJ, Gianino SM, Li K, Kesterson RA, Gutmann DH. Toonen JA, et al. Among authors: gutmann dh. Hum Mol Genet. 2016 May 1;25(9):1703-13. doi: 10.1093/hmg/ddw039. Epub 2016 Feb 16. Hum Mol Genet. 2016. PMID: 26908603 Free PMC article.

8

Contextual signaling in cancer.

Smithson LJ, Anastasaki C, Chen R, Toonen JA, Williams SB, Gutmann DH. Smithson LJ, et al. Among authors: gutmann dh. Semin Cell Dev Biol. 2016 Oct;58:118-26. doi: 10.1016/j.semcdb.2016.06.002. Epub 2016 Jun 3. Semin Cell Dev Biol. 2016. PMID: 27269372 Free PMC article. Review.

9

Challenges in Drug Discovery for Neurofibromatosis Type 1-Associated Low-Grade Glioma.

Ricker CA, Pan Y, Gutmann DH, Keller C. Ricker CA, et al. Among authors: gutmann dh. Front Oncol. 2016 Dec 20;6:259. doi: 10.3389/fonc.2016.00259. eCollection 2016. Front Oncol. 2016. PMID: 28066715 Free PMC article. Review.

10

Ccl5 establishes an autocrine high-grade glioma growth regulatory circuit critical for mesenchymal glioblastoma survival.

Pan Y, Smithson LJ, Ma Y, Hambardzumyan D, Gutmann DH. Pan Y, et al. Among authors: gutmann dh. Oncotarget. 2017 May 16;8(20):32977-32989. doi: 10.18632/oncotarget.16516. Oncotarget. 2017. PMID: 28380429 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

557 results

Search Page